Share this video  

VJHemOnc is committed to improving our service to you

ASH 2018 | CLL news from ASH 2018: ibrutinib strikes again!

Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, discusses the chronic lymphocytic leukemia (CLL) highlights at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter